50
Views
22
CrossRef citations to date
0
Altmetric
Article

The burden cost of French patients suffering from irritable bowel syndrome

, , , , , , , , & show all
Pages 336-343 | Received 16 Jul 2003, Accepted 25 Nov 2003, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

J. Fortea & M. Prior. (2013) Irritable bowel syndrome with constipation: a European-focused systematic literature review of disease burden. Journal of Medical Economics 16:3, pages 329-341.
Read now
Markku T. Hillilä, Niilo J. Färkkilä & Martti A. Färkkilä. (2010) Societal costs for irritable bowel syndrome – a population based study. Scandinavian Journal of Gastroenterology 45:5, pages 582-591.
Read now

Articles from other publishers (20)

Vivek C. Goodoory, Cho Ee Ng, Christopher J. Black & Alexander C. Ford. (2022) Direct healthcare costs of Rome IV or Rome III ‐defined irritable bowel syndrome in the United Kingdom . Alimentary Pharmacology & Therapeutics 56:1, pages 110-120.
Crossref
Florent Schäfer, Carole Faviez, Paméla Voillot, Pierre Foulquié, Matthieu Najm, Jean-François Jeanne, Guy Fagherazzi, Stéphane Schück & Boris Le Nevé. (2020) Mapping and Modeling of Discussions Related to Gastrointestinal Discomfort in French-Speaking Online Forums: Results of a 15-Year Retrospective Infodemiology Study. Journal of Medical Internet Research 22:11, pages e17247.
Crossref
Jan Tack, Vincenzo Stanghellini, Fermín Mearin, Yan Yiannakou, Peter Layer, Benoit Coffin, Magnus Simren, Jonathan Mackinnon, Gwen Wiseman & Anne Marciniak. (2019) Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries. BMC Gastroenterology 19:1.
Crossref
Fermín Mearin, Antonio M. Caballero, Jordi Serra, Carles Brotons, Ana Tantiñà, Esther Fort, Francisco J. Martínez-Cerezo, Antonia Perelló, Gloria Sánchez-Antolín, Enrique Rey, Ramón Angós Musgo, Ruth Berdier, Blas Gómez-Rodríguez, Pere Clavé, Mónica García-Alonso, Pere Torán-Monserrat & Jan Tack. (2019) A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. Gastroenterología y Hepatología 42:3, pages 141-149.
Crossref
Fermín Mearin, Antonio M. Caballero, Jordi Serra, Carles Brotons, Ana Tantiñà, Esther Fort, Francisco J. Martínez-Cerezo, Antonia Perelló, Gloria Sánchez-Antolín, Enrique Rey, Ramón Angós Musgo, Ruth Berdier, Blas Gómez-Rodríguez, Pere Clavé, Mónica García-Alonso, Pere Torán-Monserrat & Jan Tack. (2019) A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain. Gastroenterología y Hepatología (English Edition) 42:3, pages 141-149.
Crossref
L. Whigham, T. Joyce, G. Harper, P. M. Irving, H. M. Staudacher, K. Whelan & M. C. E. Lomer. (2015) Clinical effectiveness and economic costs of group versus one‐to‐one education for short‐chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome . Journal of Human Nutrition and Dietetics 28:6, pages 687-696.
Crossref
Marie-Josée J. Mangen, Martijn Bouwknegt, Ingrid H.M. Friesema, Juanita A. Haagsma, Laetitia M. Kortbeek, Luqman Tariq, Margaret Wilson, Wilfrid van Pelt & Arie H. Havelaar. (2015) Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011. International Journal of Food Microbiology 196, pages 84-93.
Crossref
C. Canavan, J. West & T. Card. (2014) Review article: the economic impact of the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics 40:9, pages 1023-1034.
Crossref
Magnus Simrén & Hans TörnblomMonica E Jarrett & Margaret M Heitkemper. 2013. Irritable Bowel Syndrome: Diagnosis and Management. Irritable Bowel Syndrome: Diagnosis and Management 57 79 .
Bijan MOGHIMI‐DEHKORDI, Mohsen VAHEDI, Mohammad Amin POURHOSEINGHOLI, Babak KHOSHKROOD MANSOORI, Azadeh SAFAEE, Manijeh HABIBI, Asma POURHOSEINGHOLI & Mohammad Reza ZALI. (2011) Economic burden attributable to functional bowel disorders in Iran: A cross‐sectional population‐based study. Journal of Digestive Diseases 12:5, pages 384-392.
Crossref
L. Sibert, J. Rigaud, D. Delavierre & J.-J. Labat. (2010) Épidémiologie et aspects économiques des douleurs pelvipérinéales chroniques. Progrès en Urologie 20:12, pages 872-885.
Crossref
S. Bruley des Varannes. (2009) Syndrome de l’intestin irritable : aspects évolutifs. Gastroentérologie Clinique et Biologique 33, pages S84-S90.
Crossref
M. Dapoigny. (2009) Syndrome de l’intestin irritable : épidémiologie/poids économique. Gastroentérologie Clinique et Biologique 33, pages S3-S8.
Crossref
Catherine Brun-Strang, Michel Dapoigny, Antoine Lafuma, Jean Pierre Wainsten & Francis Fagnani. (2007) Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. European Journal of Gastroenterology & Hepatology 19:12, pages 1097-1103.
Crossref
M. Dapoigny. (2008) Troubles fonctionnels intestinaux et impact en santé publiqueFunctional bowel disorders and their impact on Public Health. Côlon & Rectum 1:4, pages 255-258.
Crossref
Andrea Bracco, Bengt Jönsson, Jean-Francois Ricci, Michael Drummond & Henry Nyhlin. (2007) Economic Evaluation of Tegaserod vs. Placebo in the Treatment of Patients with Irritable Bowel Syndrome: An Analysis of the TENOR Study. Value in Health 10:4, pages 238-246.
Crossref
Delnaz Roshandel, Mohammadreza Rezailashkajani, Sepideh Shafaee & Mohammad Reza Zali. (2006) A cost analysis of functional bowel disorders in Iran. International Journal of Colorectal Disease 22:7, pages 791-799.
Crossref
E.M.M. Quigley, P. Bytzer, R. Jones & F. Mearin. (2006) Irritable bowel syndrome: The burden and unmet needs in Europe. Digestive and Liver Disease 38:10, pages 717-723.
Crossref
Rona L. Levy, Kevin W. Olden, Bruce D. Naliboff, Laurence A. Bradley, Carlos Francisconi, Douglas A. Drossman & Francis Creed. (2006) Psychosocial Aspects of the Functional Gastrointestinal Disorders. Gastroenterology 130:5, pages 1447-1458.
Crossref
Ebere Akobundu, Jing Ju, Lisa Blatt & C Daniel Mullins. (2006) Cost-of-Illness Studies. PharmacoEconomics 24:9, pages 869-890.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.